HSBC/CALL/AMGEN/300/0.1/16.01.26 | Market Closed - BOERSE MUENCHEN 03:36:29 2024-07-05 pm EDT | ||
| 4.7 EUR | +1.73% |
|
| Current month | -4.08% | ||
| 1 month | -0.63% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 4.7 | +1.73% |
| 24-07-04 | 4.62 | -0.86% |
| 24-07-03 | 4.66 | -2.92% |
| 24-07-02 | 4.8 | -1.03% |
| 24-07-01 | 4.85 | -1.02% |
Real-time BOERSE MUENCHEN
Last update July 05, 2024 at 03:36 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HS2FUR |
| ISIN | DE000HS2FUR7 |
| Date issued | 2023-09-28 |
| Strike | 300 $ |
| Maturity | 2026-01-16 (558 Days) |
| Parity | 10 : 1 |
| Emission price | 3.5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.07 € |
|---|---|
| Lowest since issue | 2.52 € |
| Spread | 0.02 € |
| Spread % | 0.42% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Warrants
- Warrant
